Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Randomized, Open-label Trial to Compare Low-dose ROSUvastatin Plus eZETimibe Versus High-dose Rosuvastatin in Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention

NCT04499859 is registered in ClinicalTrials.gov with Kiyuk Chang, MD,PhD as lead sponsor.

NCT NCT04499859
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04499859 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Randomized, Open-label Trial to Compare Low-dose ROSUvastatin Plus eZETimibe Versus High-dose Rosuvastatin in Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
Lead sponsor
Kiyuk Chang, MD,PhD
Phase
Phase 4
Overall status
Recruiting
Start date
October 1, 2020
Completion date
August 30, 2027
Enrollment
3,548 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

hmg-coa reductase inhibitor toxicity, myocardial infarction, statin adverse reaction